loading

Skye Bioscience Inc 주식(SKYE)의 최신 뉴스

pulisher
Jun 02, 2025

Skye Bioscience (NASDAQ:SKYE) Trading 24% HigherTime to Buy? - MarketBeat

Jun 02, 2025
pulisher
Jun 02, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Has $90,000 Stock Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Northern Trust Corp Sells 5,170 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Sold by Northern Trust Corp - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Skye Bioscience (NASDAQ:SKYE) Trading Up 24% – Should You Buy? - Defense World

May 30, 2025
pulisher
May 30, 2025

Skye Bioscience (NASDAQ:SKYE) Trading Up 24% – Here’s What Happened - Defense World

May 30, 2025
pulisher
May 27, 2025

Skye Bioscience’s SWOT analysis: obesity drug stock poised for pivotal data - Investing.com Nigeria

May 27, 2025
pulisher
May 27, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 27, 2025
pulisher
May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $923,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

May 27, 2025
pulisher
May 23, 2025

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research

May 23, 2025
pulisher
May 22, 2025

Arecor CEO on Skye Bioscience partnership and the value of collaborations - Proactive financial news

May 22, 2025
pulisher
May 22, 2025

Skye Bioscience to Participate in Upcoming Investment Conferences - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Skye Bioscience to Participate in Upcoming Investment Conferences - GlobeNewswire Inc.

May 22, 2025
pulisher
May 22, 2025

Skye Bioscience’s (SKYE) Outperform Rating Reiterated at William Blair - Defense World

May 22, 2025
pulisher
May 22, 2025

Skye Bioscience (NASDAQ:SKYE) Earns Outperform Rating from William Blair - Defense World

May 22, 2025
pulisher
May 21, 2025

Ensign Peak Advisors Inc Has $2.17 Million Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat

May 21, 2025
pulisher
May 19, 2025

Protagenic and Phytanix merger prompts a stock surge - BioWorld MedTech

May 19, 2025
pulisher
May 19, 2025

Skye Bioscience Establishes Partnership with Arecor Therapeutics - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Pre-market Movers: HCTI, PTIX, BCLI, AFMD... - RTTNews

May 19, 2025
pulisher
May 19, 2025

Arecor shares jump 10% on obesity drug partnership with Skye Bioscience - Proactive financial news

May 19, 2025
pulisher
May 19, 2025

Arecor partners with Skye Bioscience to improve formulation of obesity drug - Proactive financial news

May 19, 2025
pulisher
May 19, 2025

Skye Bioscience Partners with Arecor Therapeutics to Enhance Nimacimab Formulation for Obesity Treatment - Nasdaq

May 19, 2025
pulisher
May 19, 2025

Skye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab - The Manila Times

May 19, 2025
pulisher
May 19, 2025

Skye Bioscience Establishes Partnership with Arecor - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

New Obesity Drug Breakthrough: Skye Bioscience's Once-Weekly Treatment Gets Powerful Upgrade - Stock Titan

May 19, 2025
pulisher
May 18, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

May 18, 2025
pulisher
May 15, 2025

Skye Bioscience (NASDAQ:SKYE) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

May 15, 2025
pulisher
May 14, 2025

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Rating of “Buy” from Analysts - Defense World

May 14, 2025
pulisher
May 14, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives $16.60 Consensus PT from Analysts - Defense World

May 14, 2025
pulisher
May 14, 2025

Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) Target Price at $16.60 - Defense World

May 14, 2025
pulisher
May 13, 2025

Skye Bioscience Awards 100,000 Share Options at $1.82 with 4-Year Vesting Terms - Stock Titan

May 13, 2025
pulisher
May 13, 2025

Skye Bioscience (SKYE) Reveals Key Findings on CB1 Inhibitors an - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Skye Bioscience Clinical Model Demonstrating Necessity of - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Skye Bioscience Clinical Model Demonstrating Necessity of Peripheral CB1 Inhibition for Weight Loss Presented at European Congress on Obesity - Stock Titan

May 13, 2025
pulisher
May 13, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Bought by Barclays PLC - Defense World

May 13, 2025
pulisher
May 13, 2025

Barclays PLC Has $198,000 Stock Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

May 13, 2025
pulisher
May 12, 2025

Skye Bioscience (SKYE) Receives Adjusted Price Target from Oppen - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Oppenheimer cuts Skye Bioscience price target to $17 By Investing.com - Investing.com South Africa

May 12, 2025
pulisher
May 12, 2025

Oppenheimer cuts Skye Bioscience price target to $17 - Investing.com

May 12, 2025
pulisher
May 12, 2025

Braidwell LP Invests $2.34 Million in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat

May 12, 2025
pulisher
May 10, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Skye Bioscience, Inc. (SKYE) - ACCESS Newswire

May 10, 2025
pulisher
May 09, 2025

Earnings call transcript: Skye Bioscience Reports Q1 2025 Financials Amid R&D Expansion - Investing.com Nigeria

May 09, 2025
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
자본화:     |  볼륨(24시간):